United States Patent Application: 0080188636
ثبت نشده
چکیده
The present invention provides wood derivatives and composite materials prepared by first solvating a lignocellulosic material using an ionic liquid. The solvated lignocellulosic material can be derivatized to incorporate functional groups, particularly groups that facilitate later combination with polymer materials, including non-polymer polymers. The polymeric materials can be combined with the derivatized lignocellulosic material in solution, or the derivatized lignocellulosic material can be isolated and later combined with the polymeric material in a melt. The invention encompasses a variety of wood derivatives, composites, and nanocomposites useful for preparing multiple types of products, including membranes, fibers, and formed parts.
منابع مشابه
Heart Carcinoid Disease with Patent Foramen Ovale Treated by Mini Sternotomy
This case report was an attempt to present the importance of diagnostic echocardiography and closure of a patent foramen ovale in carcinoid heart disease. Herein, we present a case of a 48-year-old woman with a carcinoid metastasis presenting with tricuspid regurgitation, pulmonic stenosis, patent foramen ovale, and borderline left ventricular ejection fraction on an echocardiogram. Surgical in...
متن کاملIn the United States Patent and Trademark Office
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In re Application of: RICHARD H. STERN APPLICATION MADE SPECIAL Serial No.: 11/166,991 Examiner: HARRIS, CHANDA L. Filed: 27 June 2005 Art Unit: 3715 For: MENTAL THERAPY METHOD FOR CATHARSIS OF NEGATIVE FEELINGS AMENDMENT Paper No. 6 Commissioner for Patents P.O. Box 1450 Alexandria, VA 22313-1450 Sir: In response to the first Office action maile...
متن کاملDetermination of regulatory review period for purposes of patent extension; Therma Choice Uterine Ballon Therapy System. Food and Drug Administration, HHS. Notice.
The Food and Drug Administration (FDA) has determined the regulatory review period for Therma Choice5 Uterine Ballon Therapy System and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims tha...
متن کامل